Zweig Di Menna Associates LLC Amgen Inc Transaction History

Zweig Di Menna Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 29, 2019	SELL	$180.87 - $203.88 $198,957 - $224,268	-1,100 Closed	0 $0
Q4 2018 Jan 25, 2019	BUY	$178.4 - $208.25 $196,240 - $229,075	1,100 New	1,100 $214,000
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $270,064 - $301,744	-1,600 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $267,664 - $305,600	1,600	1,600 $298,000

3,055

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Zweig Di Menna Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Zweig Di Menna Associates LLC with notifications on news.